Influence of sphingosine-1-phosphate signaling on HCMV replication in human embryonal lung fibroblasts

• DOI: 10.1007/s00430-018-0543-4
• Publication Date: 2018-04-26T11:55:39Z
• Authors: Anika Zilch; Christian Rien; Cynthia Weigel; Stefanie Huskobla; Brigitte Glück; Katrin Spengler; Andreas Sauerbrei; Regine Heller; Markus Gräler; Andreas Henke
• Keywords: 0303 health sciences; Cytomegalovirus; Fibroblasts; Virus Replication; 3. Good health; Phosphotransferases (Alcohol Group Acceptor); 03 medical and health sciences; Sphingosine; Humans; Lysophospholipids; Lung; Cells, Cultured; Signal Transduction

The human cytomegalovirus (HCMV) is a common pathogen, which causes severe or even deadly diseases in immunocompromised patients. In addition, congenital HCMV infection represents a major health concern affecting especially the lung tissue of the susceptible individuals. Antivirals are a useful strategy to treat HCMV-caused diseases. However, all approved drugs target viral proteins but significant toxicity and an increasing resistance against these compounds have been observed. In infected cells, numerous host molecules have been identified to play important roles during HCMV replication. Among others, HCMV infection depends on the presence of bioactive sphingolipids. In this study, the role of sphingosine-1-phosphate (S1P) signaling in HCMV-infected human embryonal lung fibroblasts (HELF) was analyzed. Viral replication depended on the functional activity of sphingosine kinases (SK). During SK inhibition, addition of extracellular S1P restored HCMV replication. Moreover, neutralization of extracellular S1P by anti-S1P antibodies decreased HCMV replication as well. While the application of FTY720 as an functional antagonist of S1P receptor (S1PR)1,3-5 signaling did not reduce HCMV replication significantly, JTE-013, an inhibitor of S1PR2, decreased viral replication. Furthermore, inhibition of Rac-1 activity reduced HCMV replication, whereas inhibition of the Rac-1 effector protein Rac-1-activated kinase 1 (PAK1) had no influence. In general, targeting S1P-induced pathways, which are essential for a successful HCMV replication, may represent a valuable strategy to develop new antiviral drugs.